D’Alise, A., Nocchi, L., Garzia, I., Seclì, L., Infante, L., Troise, F., … Nicosia, A. (2023). Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer. Frontiers in Immunology, 14, 1156714. https://doi.org/10.3389/fimmu.2023.1156714 (Original work published 2023)
vaccine
Yu, J., Thomas, P. , V, Sciacca, M., Wu, C., Liu, J., He, X., … Barouch, D. (2023). Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques. Cell Reports. Medicine, 4(4), 101018. https://doi.org/10.1016/j.xcrm.2023.101018 (Original work published 2023)
Liu, W., Li, H., Liu, B., Lv, T., Yang, C., Chen, S., … Chen, L. (2023). A new vaccination regimen using adenovirus-vectored vaccine confers effective protection against African swine fever virus in swine. Emerging Microbes & Infections, 12(2), 2233643. https://doi.org/10.1080/22221751.2023.2233643 (Original work published 2023)
Wen, Z., Fang, C., Liu, X., Liu, Y., Li, M., Yuan, Y., … Sun, C. (2023). A recombinant Mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine. Human Vaccines & Immunotherapeutics, 19(1), 2171233. https://doi.org/10.1080/21645515.2023.2171233 (Original work published 2023)
Gong, H., Liu, Y., Yan, B., & Liu, F. (2025). Antiviral Immune Responses Against Murine Cytomegalovirus Induced by an Oral Salmonella-Based Vaccine Expressing Viral M33 Protein. Microorganisms, 13(7). https://doi.org/10.3390/microorganisms13071510 (Original work published 2025)
Zhou, L., Yang, Y., Mo, C., Zhu, Y., Fan, Y., Liu, W., … Tian, X. (2025). Human adenovirus penton dodecahedron nanoparticles induce an enhanced neutralizing antibody response in mouse model. Vaccine, 61, 127380. https://doi.org/10.1016/j.vaccine.2025.127380 (Original work published 2025)
Seclì, L., Nocchi, L., Leoni, G., Cotugno, G., Troise, F., Romano, G., … D’Alise, A. (2025). Neoadjuvant personalized viral vaccine prevents tumor relapse in checkpoint-resistant murine melanoma model. Journal for Immunotherapy of Cancer, 13(11). https://doi.org/10.1136/jitc-2025-013035 (Original work published 2025)
Alby-Laurent, F., Ouedrani, A., Jateau, P., Strullu, M., Walter-Petrich, A., Mrad, C., … Petit, A. (2026). Safety and immunogenicity of BNT162b2 vaccine in children with acute leukaemia: results and perspectives of an open-label, two-centre, phase 1/2 trial with dose finding study. Vaccine, 74, 128130. https://doi.org/10.1016/j.vaccine.2025.128130 (Original work published 2026)
Feng, Y., Shu, T., Li, L., Sun, X., Yu, C., Liu, W., … Chen, L. (2026). A replication-incompetent adenovirus type 55 vaccine induces broad and durable protective immunity against pathogenic adenoviruses. Molecular Therapy : The Journal of the American Society of Gene Therapy, 34(3), 1597-1615. https://doi.org/10.1016/j.ymthe.2025.12.027 (Original work published 2026)
Liu, Y., Gong, H., Zhu, J., & Liu, F. (2026). An Oral Vaccine Derived from Attenuated Salmonella Producing Murine Cytomegalovirus M24 Protein Induces Successful Antiviral Immune Responses in Mice. Vaccines, 14(3). https://doi.org/10.3390/vaccines14030279 (Original work published 2026)